Cargando…
Sensitive Detection of Pre-Existing BCR-ABL Kinase Domain Mutations in CD34+ Cells of Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients Is Associated with Imatinib Resistance: Implications in the Post-Imatinib Era
BACKGROUND: BCR-ABL kinase domain mutations are infrequently detected in newly diagnosed chronic-phase chronic myeloid leukemia (CML) patients. Recent studies indicate the presence of pre-existing BCR-ABL mutations in a higher percentage of CML patients when CD34+ stem/progenitor cells are investiga...
Autores principales: | Iqbal, Zafar, Aleem, Aamer, Iqbal, Mudassar, Naqvi, Mubashar Iqbal, Gill, Ammara, Taj, Abid Sohail, Qayyum, Abdul, ur-Rehman, Najeeb, Khalid, Ahmad Mukhtar, Shah, Ijaz Hussain, Khalid, Muhammad, Haq, Riazul, Khan, Mahwish, Baig, Shahid Mahmood, Jamil, Abid, Abbas, Muhammad Naeem, Absar, Muhammad, Mahmood, Amer, Rasool, Mahmood, Akhtar, Tanveer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568121/ https://www.ncbi.nlm.nih.gov/pubmed/23409026 http://dx.doi.org/10.1371/journal.pone.0055717 |
Ejemplares similares
-
Discovery and Protein Modeling Studies of Novel Compound Mutations Causing Resistance to Multiple Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
por: Iqbal, Zafar, et al.
Publicado: (2020) -
Integrated Genomic Analysis Identifies ANKRD36 Gene as a Novel and Common Biomarker of Disease Progression in Chronic Myeloid Leukemia
por: Iqbal, Zafar, et al.
Publicado: (2021) -
Imatinib independent aberrant methylation of NOV/CCN3 in chronic myelogenous leukemia patients: a mechanism upstream of BCR-ABL1 function?
por: Vatanmakanian, Mousa, et al.
Publicado: (2019) -
Imatinib: A Breakthrough of Targeted Therapy in Cancer
por: Iqbal, Nida, et al.
Publicado: (2014) -
Cantharidin Overcomes Imatinib Resistance by Depleting BCR-ABL in Chronic Myeloid Leukemia
por: Sun, Xiaoyan, et al.
Publicado: (2016)